Advances in research on α-linolenic acid in metabolic syndrome and related cardiovascular injury.

α-linolenic acid is a naturally occurring ω-3 polyunsaturated fatty acid that is essential for human health but cannot be synthesized by the body and must be obtained through the diet. Studies have demonstrated that α-linolenic acid offers a variety of health benefits, particularly showing potential in the prevention and adjunctive treatment of metabolic syndrome. In terms of lipid-lowering effects, α-linolenic acid suppresses the expression of genes involved in cholesterol and triglyceride synthesis, while promoting the expression of genes related to fatty acid oxidation. In cardiovascular protection, α-linolenic acid prevents or ameliorates atherosclerosis by improving endothelial function, inhibiting thrombosis, and reducing oxidative stress and inflammation. Although some clinical studies show that α-linolenic acid can lower lipids, regulate blood glucose, and provide cardiovascular protection, other studies suggest its effects may not be entirely consistent. Therefore, while α-linolenic acid has potential value in regulating lipid metabolism, inflammatory responses, and cellular signaling pathways, especially in metabolic diseases and cardiovascular protection, its clinical effects still exhibit certain heterogeneity.
Cardiovascular diseases
Care/Management

Authors

Wan Wan, Li Li, Zhang Zhang, Fan Fan, Feng Feng
View on Pubmed
Share
Facebook
X (Twitter)
Bluesky
Linkedin
Copy to clipboard